A Virus-Infected, Reprogrammed Somatic cell-derived Tumor cell (VIReST) vaccination regime can prevent initiation and progression of pancreatic cancer.

CONCLUSIONS: These results provide both proof of concept and a robust technology platform for personalized prophylactic cancer vaccines to prevent pancreatic malignancies in at-risk individuals.
PMID: 31767564 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - November 24, 2019 Category: Cancer & Oncology Authors: Lu S, Zhang Z, Du P, Chard LS, Yan W, El-Khouri M, Wang Z, Zhang Z, Chu Y, Gao D, Zhang Q, Zhang L, Nagano A, Wang J, Chelala C, Liu J, Chen J, Liu P, Dong Y, Wang S, Li X, Dong J, Lemoine NR, Pei D, Wang Y Tags: Clin Cancer Res Source Type: research